Skip to content
type1.science
Phase 3RecruitingNCT06894784

SEMPA: semaglutide plus empagliflozin added to AID

McGill phase 3 crossover study testing semaglutide and empagliflozin, individually and combined, as adjuncts to automated insulin delivery in adults with T1D.

Primary endpoints

  • Time in range

Results so far

No results posted yet.